Huntsman Ronald Kirk 4
4 · Vivos Therapeutics, Inc. · Filed May 25, 2021
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2021-05-25$5.38/sh+4,000$21,520→ 5,500 total
Holdings
- 333,334
Stock Option
Exercise: $1.65Exp: 2022-09-30→ Common Stock (333,334 underlying) - 1,749,000(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.335 to $5.40.
- [F2]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
- [F3]The option provides for vesting in five equal annual installments beginning on January 15, 2017.